Robert F. Kennedy Jr., President-elect Donald Trump‘s nominee to lead the Department of Health and Human Services, wants to ...

Summary Apixaban is an oral ... regimen in clinical trials without the need for anticoagulation monitoring or dosage adjustment. Apixaban has multiple elimination pathways, and its ...

The patent expiry of key drugs in 2025-26 will open up additional market space for Indian manufacturers of generics and ...

For example, Lexapro can interact with apixaban (Eliquis ... For more information about this drug, see this Lexapro overview article. Before you start taking Lexapro, tell your doctor and ...

The data forecasts the top 10 best-selling drugs in 2025 by annual revenue. Following Keytruda, Bristol-Myers Squibb (BMS) and Pfizer's Eliquis (apixaban), an oral anticoagulant, will be the ...

Medicare will negotiate drug prices for popular medications like Ozempic and Wegovy, aiming to save billions for taxpayers ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

The top 10 patented drugs getting expired in the coming years in the US, include Pembrolizumab, sold under the brand name Keytruda by Merck and Co., Eliquis (Apixaban) sold by Bristol Myers Squibb ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Big Pharma will hunt for more acquisitions in 2025 as industry giants face patent expiration for some of their best-selling drugs, according to a top M&A banker. Merck's cancer drug Keytruda, the ...

They included popular blood thinners Xarelto and Eliquis and diabetes drugs Jardiance and Januvia.The savings from the new list prices for those drugs were expected to generate about $6 billion ...